These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12004465)

  • 1. Visual compatibility of azithromycin with 24 commonly used drugs during simulated Y-site delivery.
    Voytilla KL; Tyler LS; Rusho WJ
    Am J Health Syst Pharm; 2002 May; 59(9):853-5. PubMed ID: 12004465
    [No Abstract]   [Full Text] [Related]  

  • 2. Visual compatibility of oritavancin diphosphate with selected coadministered drugs during simulated Y-site administration.
    Kumar A; Mann HJ
    Am J Health Syst Pharm; 2010 Oct; 67(19):1640-4. PubMed ID: 20852166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual compatibility of gallium nitrate with selected drugs during simulated Y-site injection.
    Lober CA; Dollard PA
    Am J Hosp Pharm; 1993 Jun; 50(6):1208-10. PubMed ID: 8517464
    [No Abstract]   [Full Text] [Related]  

  • 4. Physical compatibility of ceftolozane-tazobactam with selected i.v. drugs during simulated Y-site administration.
    Thabit AK; Hamada Y; Nicolau DP
    Am J Health Syst Pharm; 2017 Jan; 74(1):e47-e54. PubMed ID: 28007721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration.
    Singh BN; Dedhiya MG; DiNunzio J; Chan P; Kupiec TC; Trissel LA; Laudano JB
    Am J Health Syst Pharm; 2011 Nov; 68(22):2163-9. PubMed ID: 22058102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical compatibility of tedizolid phosphate with selected i.v. drugs during simulated Y-site administration.
    Ghazi I; Hamada Y; Nicolau DP
    Am J Health Syst Pharm; 2016 Nov; 73(21):1769-1776. PubMed ID: 27769972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compatibility of selected critical care drugs during simulated Y-site administration.
    Yamashita SK; Walker SE; Choudhury T; Iazzetta J
    Am J Health Syst Pharm; 1996 May; 53(9):1048-51. PubMed ID: 8744469
    [No Abstract]   [Full Text] [Related]  

  • 8. Single-dose azithromycin microsphere formulation: a novel delivery system for antibiotics.
    Amrol D
    Int J Nanomedicine; 2007; 2(1):9-12. PubMed ID: 17722506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration.
    Housman ST; Tessier PR; Nicolau DP; Kuti JL
    Am J Health Syst Pharm; 2011 Dec; 68(23):2265-70. PubMed ID: 22095816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration.
    Avery LM; Chen IH; Reyes S; Nicolau DP; Kuti JL
    Clin Ther; 2019 Oct; 41(10):2162-2170. PubMed ID: 31506218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual compatibility of diltiazem injection with various diluents and medications during simulated Y-site injection.
    Gayed AA; Keshary PR; Hinkle RL
    Am J Health Syst Pharm; 1995 Mar; 52(5):516-20. PubMed ID: 7606558
    [No Abstract]   [Full Text] [Related]  

  • 12. Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration.
    Chan P; Bishop A; Kupiec TC; Trissel LA; Gole D; Jimidar IM; Vermeersch H
    Am J Health Syst Pharm; 2008 Aug; 65(16):1545-51. PubMed ID: 18693210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of azithromycin nanosuspensions by reactive precipitation method.
    Hou CD; Wang JX; Le Y; Zou HK; Zhao H
    Drug Dev Ind Pharm; 2012 Jul; 38(7):848-54. PubMed ID: 22092042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual compatibility of tacrolimus with commonly used drugs during simulated Y-site injection.
    Min DI; Brown T; Hwang GC
    Am J Hosp Pharm; 1992 Dec; 49(12):2964-6. PubMed ID: 1282779
    [No Abstract]   [Full Text] [Related]  

  • 15. Physical and chemical compatibility of daptomycin with nine medications.
    Lai JJ; Brodeur SK
    Ann Pharmacother; 2004 Oct; 38(10):1612-6. PubMed ID: 15328397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical and chemical compatibility of drotrecogin alfa (activated) with 34 drugs during simulated Y-site administration.
    Mann HJ; Demmon SL; Boelk DA; Payne CA; Effron MB; Rajagopalan N; Williams MD; Beck GM; Gopalrathnam G
    Am J Health Syst Pharm; 2004 Dec; 61(24):2664-71. PubMed ID: 15646701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicochemical aspects of the coformulation of colistin and azithromycin using liposomes for combination antibiotic therapies.
    Wallace SJ; Nation RL; Li J; Boyd BJ
    J Pharm Sci; 2013 May; 102(5):1578-87. PubMed ID: 23526658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual compatibility of acyclovir sodium with commonly used intravenous drugs simulated Y-site injection.
    Forman JK; Lachs JR; Souney PF
    Am J Hosp Pharm; 1987 Jun; 44(6):1408-9. PubMed ID: 3618621
    [No Abstract]   [Full Text] [Related]  

  • 19. Visual compatibility of diltiazem with commonly used injectable drugs during simulated Y-site administration.
    Zanetti LA
    Am J Hosp Pharm; 1992 Aug; 49(8):1911. PubMed ID: 1442831
    [No Abstract]   [Full Text] [Related]  

  • 20. Compatibility of cefepime and vancomycin during simulated Y-site administration of prolonged infusion.
    Berti AD; Hutson PR; Schulz LT; Webb AP; Rose WE
    Am J Health Syst Pharm; 2015 Mar; 72(5):390-5. PubMed ID: 25694414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.